$37.79 +0.40 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - New York Stock Exchange, Inc.

Dec. 9, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. BP: Asset Sales, New Projects Fuel Its 6.7% Dividend Yield

    TalkMarkets | Dec. 6, 2016 | 14:20PM EST
  2. GlaxoSmithKline: Robust Pipeline Supports its 5.5% Dividend Yield

    TalkMarkets | Dec. 4, 2016 | 11:46AM EST
  3. GSK: Robust Pipeline Supports its 5.5% Dividend Yield

    TalkMarkets | Dec. 4, 2016 | 11:46AM EST
  4. Better Than The Maestro

    TalkMarkets | Nov. 28, 2016 | 23:53PM EST
  5. 6 Worthy Dividend Stocks Down 10% Or More

    TalkMarkets | Nov. 24, 2016 | 03:57AM EST
  6. Musings And Global Markets

    TalkMarkets | Nov. 12, 2016 | 16:28PM EST
  7. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  8. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  9. Week In Review: China Healthcare And Pharma Deals

    TalkMarkets | Oct. 22, 2016 | 14:05PM EST
  10. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al

    TalkMarkets | Oct. 21, 2016 | 19:05PM EST
  11. Week In Review: China Resources Pharma To Price $2 Billion Hong Kong IPO This Week

    TalkMarkets | Oct. 15, 2016 | 14:42PM EST
  12. Seven Sources of Competitive Advantage

    TalkMarkets | Oct. 9, 2016 | 15:31PM EST
  13. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 12:20PM EST
  14. Alphabet-Glaxo Joint Venture Targets 'Bioelectronics'

    Investors Business Daily | Aug. 1, 2016 | 09:13AM EST
  15. Veeva Is Key Partner In Big Pharma's Race Against The Clock

    Investors Business Daily | Jul. 29, 2016 | 07:00AM EST
  16. Stock Futures Up, Gaining Strength; Apple Hauls Techs Higher

    Investors Business Daily | Jul. 27, 2016 | 07:00AM EST
  17. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  18. Getting to Know VBI Vaccines

    GuruFocus | Jul. 13, 2016 | 12:04PM EST
  19. Brandes Makes a Variety of Reductions in 4th Quarter

    GuruFocus | Feb. 11, 2016 | 18:19PM EST
  20. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  21. EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4

    Benzinga | Jan. 29, 2016 | 13:38PM EST
  22. Benzinga's M&A Chatter for Thursday January 28, 2015

    Benzinga | Jan. 28, 2016 | 23:27PM EST
  23. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  24. Stocks Bring High Dividend Yields to HOTCHKIS & WILEY

    GuruFocus | Jan. 14, 2016 | 12:05PM EST
  25. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 15:40PM EST
  26. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 14:51PM EST
  27. Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Jan. 4, 2016 | 17:46PM EST
  28. Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment

    GuruFocus | Jan. 4, 2016 | 14:02PM EST
  29. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  30. High Dividend Yield Ratios Are Hallmarks of Many Dodge & Cox Stakes

    GuruFocus | Dec. 21, 2015 | 10:58AM EST
  31. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD | Dec. 18, 2015 | 14:05PM EST
  32. John Rogers' Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Dec. 16, 2015 | 16:40PM EST
  33. 3 Global Investment Ideas From Gurus

    GuruFocus | Dec. 10, 2015 | 14:57PM EST
  34. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  35. Skin Disease Drug Costs Jump

    IBD | Nov. 25, 2015 | 18:34PM EST
  36. Valeant, Glaxo, Novartis Skin Drug Prices Have Soared

    IBD | Nov. 25, 2015 | 17:01PM EST
  37. Dodge & Cox Sells Most of Stakes in Chevron, GlaxoSmithKline

    GuruFocus | Nov. 17, 2015 | 18:46PM EST
  38. 3 Investment Ideas of Ariel Investment's Rupal Bhansali

    GuruFocus | Nov. 16, 2015 | 09:57AM EST
  39. Pfizer to Create a New Pharmaceutical Colossus

    GuruFocus | Nov. 5, 2015 | 13:20PM EST
  40. GlaxoSmithKline

    IBD | Oct. 28, 2015 | 17:47PM EST
  41. Gilead Beats Q3 Estimates As HIV Franchise Shines

    IBD | Oct. 27, 2015 | 16:03PM EST
  42. ISIS Pharmaceuticals Earns $5M from GSK for Initiation of Phase 1 Study of ISIS-GSK4-L Rx

    Benzinga | Oct. 26, 2015 | 06:03AM EST
  43. Benzinga's Top Upgrades

    Benzinga | Oct. 20, 2015 | 08:11AM EST
  44. IBM, Schlumberger PTs Lowered; Valeant Downgraded

    IBD | Oct. 20, 2015 | 07:38AM EST
  45. GlaxoSmithKline Has a High (and Dangerous) Dividend Yield

    GuruFocus | Oct. 19, 2015 | 13:32PM EST
  46. Tweedy Browne Global Value Adds to Stake in GlaxoSmithKline

    GuruFocus | Oct. 14, 2015 | 17:23PM EST
  47. Liquidia Technologies And GlaxoSmithKline Advance Existing Collaboration; GlaxoSmithKline Exercises Option For Inhaled Therapeutics

    Benzinga | Sep. 30, 2015 | 11:44AM EST
  48. 3 Big Drugs Likely To Hit The Market Soon

    IBD | Sep. 30, 2015 | 11:34AM EST
  49. Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD ...

    GuruFocus | Sep. 24, 2015 | 23:03PM EST
  50. Guru Stocks at 52-Week Lows: RDS.A, PTR, UL, BP, GSK

    GuruFocus | Sep. 12, 2015 | 23:57PM EST
Trading Center